Title: Preclinical Studies of Bismuth-213 Labeled Plasminogen Activator Inhibitor Type 2 (PAI2) in a Prostate Cancer Nude Mouse Xenograft Model
Authors: RIZVI S.m.a.LI Y.SONG E.QU C.f.RAJA C.MORGENSTERN ALFREDAPOSTOLIDIS CHRISTOSALLEN B.j.
Citation: CANCER BIOLOGY & THERAPY vol. 5 p. 386-393
Publisher: LANDES BIOSCIENCE
Publication Year: 2006
JRC Publication N°: JRC35141
URI: http://publications.jrc.ec.europa.eu/repository/handle/JRC35141
Type: Articles in Journals
Abstract: The key objective of the study was to determine the single and multiple does toxicity and efficay of Bismuth-213 labeled PAI2 based targeted alpha therapy by selectively targeting uPA and uPAR in regressing prostate cancer in a nude mouse model.
JRC Institute:Institute for Transuranium Elements

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.